
Tuesday, November 01, 2022 10:05:27 AM
https://finance.yahoo.com/news/pfizer-reports-strong-third-quarter-104500928.html
2022 guidance for Comirnaty (COVID vaccine) is now $34B (from prior $32B). 2022 guidance of Paxlovid remains $22B.
2022 non-GAAP EPS guidance is now $6.40-6.50 (from the prior range of $6.30-6.45), despite an increased headwind from currency exchange rates (i.e. the strong US dollar).
CC slides:
https://s28.q4cdn.com/781576035/files/doc_financials/2022/q3/Q3-2022-Earnings-Charts-FINAL.pdf
Transcript of CC prepared remarks:
https://s28.q4cdn.com/781576035/files/doc_financials/2022/q3/Q3-2022-Earnings-Conference-Call-Prepared-Remarks-FINAL-(1).pdf
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Liked By
Spread the love. Be the first to like this post!
Recent PFE News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/31/2023 01:12:29 PM
- PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE • Business Wire • 01/31/2023 11:45:00 AM
- EU Might Buy Fewer Vaccine Doses From Pfizer, BioNTech for Higher Price, Reuters Reports • Dow Jones News • 01/27/2023 01:50:00 PM
- When Does Pfizer Become A Bargain? • ValueWalk • 01/24/2023 11:04:42 PM
- Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries • Business Wire • 01/17/2023 11:45:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:51 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:34 PM
- Pfizer Gets FDA Priority Review of Prevnar 20 for Kids • Dow Jones News • 01/06/2023 12:26:00 PM
- U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children • Business Wire • 01/06/2023 11:45:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:10 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:07 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:04 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 10:51:19 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 10:51:06 PM
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 01/03/2023 03:00:00 PM
- China Approves Merck's Molnupiravir for Emergency Use, Regulator Says -- Update • Dow Jones News • 12/30/2022 12:33:00 PM
- Pfizer's Hemophilia Therapy Study Meets Key Targets • Dow Jones News • 12/29/2022 12:55:00 PM
- Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate • Business Wire • 12/29/2022 11:45:00 AM
- Pfizer Says FDA to Review Meningococcal Vaccine Application • Dow Jones News • 12/28/2022 12:50:00 PM
- U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents • Business Wire • 12/28/2022 11:45:00 AM
- Oric Pharmaceuticals Shares Soar on Pfizer's $25 Million Investment • Dow Jones News • 12/22/2022 12:40:00 PM
- U.S., EU Regulators to Review Pfizer's Ulcerative Colitis Treatment • Dow Jones News • 12/21/2022 12:40:00 PM
- Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis • Business Wire • 12/21/2022 11:45:00 AM
TNRG Files A Reg A Offering, To Raise $75 million • TNRG • Feb 1, 2023 10:07 AM
IQST - iQSTEL Announces Board Election and CPA Ratification Following Annual Shareholder Meeting • IQST • Feb 1, 2023 10:04 AM
1606 Corp. (OTC | CBDW) to Produce a New Inventory of CBD Smokables to Supply an Additional 2500 Retail Outlets, Engages Direct Marketing Expert to Head Efforts • CBDW • Feb 1, 2023 8:30 AM
ITRONICS RECEIVES VALUATION REPORT FOR ITS INTELLECTUAL PROPERTY TO OBTAIN NON-DILUTIVE FINANCING • ITRO • Feb 1, 2023 6:30 AM
Kona Gold Beverage, Inc Announces Distribution Agreement with Norman Distribution in Illinois • KGKG • Jan 31, 2023 9:00 AM
PSYC Provides Shareholders with Key Corporate Updates and Highlights Objectives for 2023 • PSYC • Jan 31, 2023 8:30 AM